Neuland Laboratories Ltd.

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1984

Chairman: Davuluri Rama Mohan Rao

Managing Director: Davuluri Rama Mohan Rao

Group: --

Listing: NSE: NEULANDLAB, BSE: 524558

Headquarters: Hyderabad, Telangana

Website: www.neulandlabs.com

Market cap: R 1,775.08 Cr

Revenue (TTM): R 842.30 Cr

Earnings (TTM): R 38.42 Cr

Cash: R 54.48 Cr

Total Debt: R 259.59 Cr

Promoters' ownership: 36.25%

Liquidity: High

52 Week range: R 245.75 - 1,465.00

Face value: R10.00

Shares outstanding: 1,28,29,889

10 Years Aggregate:

• CFO: 391.47 Cr
• EBITDA: 686.45 Cr
• Net Profit: 183.00 Cr